Navigation Links
Talecris Names John Perkins as Executive Vice President, Global Commercial Operations

RESEARCH TRIANGLE PARK, N.C., June 3 /PRNewswire-FirstCall/ -- Talecris Biotherapeutics Holdings Corp. (Nasdaq: TLCR) today announced the promotion of John R. Perkins to the position of executive vice president, global commercial operations.

In this leadership position, Perkins will be responsible for the global commercial business, including worldwide portfolio management, sales and marketing.

"John has demonstrated strong leadership and a proven track record of success," said Lawrence D. Stern, chairman and CEO of Talecris. "I am confident that his experience and diverse skill set will enable the seamless development and execution of our global strategies to drive global growth."

Perkins joined Talecris Biotherapeutics in 2006 and most recently served as the senior vice president and general manager, portfolio management and U.S. business.  He also serves on the board of directors for Centric Health Resources.

Prior to joining Talecris, Perkins was an operations executive at Cerberus Capital. He previously held a variety of positions at General Electric in corporate business development (M&A), marketing and product management, sales, operations and corporate audit.

Perkins received his Bachelor of Arts degree from DePauw University and his Master of Business Administration degree from Northwestern University's Kellogg School of Management.

About Talecris Biotherapeutics: Inspiration. Dedication. Innovation. Talecris Biotherapeutics is a global biotherapeutic and biotechnology company that discovers, develops and produces critical care treatments for people with life-threatening disorders in a variety of therapeutic areas including immunology, pulmonology, neurology and hemostasis.

SOURCE Talecris Biotherapeutics
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Talecris Biotherapeutics to Present at the 2010 Citi Investment Research Global Health Care Conference
2. Talecris Added to NASDAQ Biotechnology Index
3. Talecris Biotherapeutics to Present at the Bank of America Merrill Lynch Health Care Conference
4. Talecris Biotherapeutics to Report First Quarter 2010 Financial Results
5. Siemens/Talecris Win Best Partnership in the Outsourcing Excellence Awards
6. Live Webinar: Paperless QC Micro Implemented by Talecris Biotherapeutics
7. The Alpha-1 Foundation Awards Two Research Grants with Support from Talecris Biotherapeutics, Inc.
8. CSL Limited and Talecris Biotherapeutics Agree to Terminate Merger Agreement
9. Chimerix Names George Painter, Ph.D., Chairman of the Board and Chief Scientific Officer; Appoints Kenneth I. Moch President and Chief Executive Officer
10. Transgenomic Names Dr. Katherine Richardson Technical Director for Laboratory Services
11. Thomson Reuters Names the Worlds Hottest Researchers
Post Your Comments:
(Date:6/23/2016)... June 23, 2016 /PRNewswire/ - FACIT has announced ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" ... commercialization of a portfolio of first-in-class WDR5 inhibitors ... such as WDR5 represent an exciting class of ... precision medicine for cancer patients. Substantial advances have ...
(Date:6/23/2016)... YORK , June, 23, 2016  The Biodesign ... to envision new ways to harness living systems and ... Modern Art (MoMA) in New York City ... than 130 participating students, showcased projects at MoMA,s Celeste ... Paola Antonelli , MoMA,s senior curator of architecture ...
(Date:6/23/2016)... 2016 Apellis Pharmaceuticals, Inc. today announced ... of its complement C3 inhibitor, APL-2. The trials ... dose studies designed to assess the safety, tolerability, ... in healthy adult volunteers. Forty subjects ... single dose (ranging from 45 to 1,440mg) or ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... regulatory and technical consulting, provides a free webinar on Performing Quality ... 13, 2016 at 12pm CT at no charge. , Incomplete investigations are still ...
Breaking Biology Technology:
(Date:6/21/2016)... 21, 2016 NuData Security announced today that ... of principal product architect and that Jon ... customer development. Both will report directly to ... moves reflect NuData,s strategic growth in its product ... customer demand and customer focus values. ...
(Date:6/15/2016)... New York , June 15, 2016 /PRNewswire/ ... a new market report titled "Gesture Recognition Market by ... and Forecast, 2016 - 2024". According to the report, ... USD 11.60 billion in 2015 and is estimated ... reach USD 48.56 billion by 2024.  ...
(Date:6/7/2016)... 7, 2016  Syngrafii Inc. and San Antonio ... that includes integrating Syngrafii,s patented LongPen™ eSignature "Wet" ... collaboration will result in greater convenience for SACU ... while maintaining existing document workflow and compliance requirements. ... Highlights: ...
Breaking Biology News(10 mins):